1. Home
  2. BSX vs SNPS Comparison

BSX vs SNPS Comparison

Compare BSX & SNPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

HOLD

Current Price

$53.95

Market Cap

93.4B

Sector

Health Care

ML Signal

HOLD

Logo Synopsys Inc.

SNPS

Synopsys Inc.

HOLD

Current Price

$515.09

Market Cap

96.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSX
SNPS
Founded
1979
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
93.4B
96.6B
IPO Year
2010
1994

Fundamental Metrics

Financial Performance
Metric
BSX
SNPS
Price
$53.95
$515.09
Analyst Decision
Strong Buy
Buy
Analyst Count
22
14
Target Price
$93.18
$540.71
AVG Volume (30 Days)
16.2M
1.6M
Earning Date
04-22-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
55.20
N/A
EPS
0.90
0.34
Revenue
$9,076,000,000.00
$5,081,542,000.00
Revenue This Year
$11.85
$39.22
Revenue Next Year
$10.16
$10.73
P/E Ratio
$63.11
$1,484.10
Revenue Growth
12.49
20.87
52 Week Low
$54.98
$376.18
52 Week High
$109.50
$651.65

Technical Indicators

Market Signals
Indicator
BSX
SNPS
Relative Strength Index (RSI) 29.22 70.93
Support Level N/A $409.90
Resistance Level $76.77 $535.20
Average True Range (ATR) 2.04 14.94
MACD -0.28 2.86
Stochastic Oscillator 1.01 93.95

Price Performance

Historical Comparison
BSX
SNPS

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

About SNPS Synopsys Inc.

Synopsys is a provider of electronic design automation software and intellectual property products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Synopsys' comprehensive portfolio is benefiting from a convergence of semiconductor companies moving up the stack of technologies toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.

Share on Social Networks: